Abstract:Cyclooxgenases are key enzymes of lipid signaling. They carry out the first step in the production of prostaglandins, important mediators of inflammation, pain, cardiovascular disease, and cancer, and they are the molecular targets for nonsteroidal anti-inflammatory drugs, which are among the oldest and most chemically diverse set of drugs known. Homodimeric proteins that behave as allosterically modulated, functional heterodimers, the cyclooxygenases exhibit complex kinetic behavior, requiring peroxide-dependent activation and undergoing suicide inactivation. Due to their important physiological and pathophysiological roles and keen interest on the part of the pharmaceutical industry, the cyclooxygenases have been the focus of a vast array of structural studies, leading to the publication of over 80 crystal structures of the enzymes in complex with substrates or inhibitors supported by a wealth of functional data generated by site-directed mutation experiments. In this review, we explore the chemical biology of the cyclooxygenases through the lens of this wealth of structural and functional information. We identify key structural features of the cyclooxygenases, break down their active site into regional binding pockets to facilitate comparisons between structures, and explore similarities and differences in the binding modes of the wide variety of ligands (both substrates and inhibitors) that have been characterized in complex with the enzymes. Throughout, we correlate structure with function whenever possible. Finally, we summarize what can and cannot be learned from the currently available structural data and discuss the critical intriguing questions that remain despite the wealth of information that has been amassed in this field.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.chemrev.0c00215.(Table S1) Crystal Structures; (Table S2) site-directed mutations of cyclooxygenase isoforms; (Figures S1 to S20) both wall-eyed and cross-eyed format; and (Figures 1 to 24) cross-eyed format (PDF)This article has not yet been cited by other publications.

Regulation of T Helper Cell Subsets by Cyclooxygenases and Their Metabolites.

Cyclo-Oxygenase 2 Up-Regulates the Effect of Multidrug Resistance

Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity.

Cyclooxygenase-1 Regulates the Development of Follicular Th Cells via Prostaglandin E<sub>2</sub>

The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells

The Signaling Pathway of PGE2 and Its Regulatory Role in T Cell Differentiation.

Structural and Chemical Biology of the Interaction of Cyclooxygenase with Substrates and Non-Steroidal Anti-Inflammatory Drugs

The Functions of Cytochrome P450 ω-hydroxylases and the Associated Eicosanoids in Inflammation-Related Diseases

Prostanoids in health and disease

Cyclopentenone Isoprostanes Inhibit the Inflammatory Response in Macrophages

The Eicosanoids, Redox-Regulated Lipid Mediators in Immunometabolic Disorders

Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells

Cyclooxygenase-2 Expressed Hepatocellular Carcinoma Induces Cytotoxic T Lymphocytes Exhaustion Through M2 Macrophage Polarization.

Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer

Cyclooxygenases: From Prostaglandin Synthesis to Innovative Therapies for Inflammation

Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature

Inhibitors of cyclooxygenases: mechanisms, selectivity and uses

Cyclooxygenase-2 in human pathological disease

Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation

Activity-dependent COX-2 proteolysis generates a catalytically inactive fragment that affects aerobic respiration and proliferation

Regulated Spatial Distribution Of Cyclooxygenases And Lipoxygenases In Crohn'S Ulcer